中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
The use of polymeric platinum(IV) prodrugs to deliver multinuclear platinum(II) drugs with reduced systemic toxicity and enhanced antitumor efficacy

文献类型:期刊论文

作者Xiao HH ; Song HQ ; Zhang Y ; Qi RG ; Wang R ; Xie ZG ; Huang YB ; Li YX ; Wu Y ; Jing XB
刊名biomaterials
出版日期2012
卷号33期号:33页码:8657-8669
关键词CONFORMATIONAL-CHANGES BIS(PLATINUM) COMPLEXES BIODEGRADABLE POLYMER ANTICANCER AGENTS DNA-BINDING PHASE-I TRINUCLEAR CARBOXYLATION CISPLATIN(IV) CYTOTOXICITY
ISSN号0142-9612
通讯作者jing xb
中文摘要two dinuclear platinum(iv) prodrugs were prepared from cisplatin and oxaliplatin, and tethered to amphiphilic biodegradable block copolymers. the polymeric dinuclear platinum(iv) prodrugs were allowed to self-assemble into nanomicelles, which showed reduced systemic toxicity, relatively long blood circulation, and enhanced antitumor efficacy. in this way, the bottleneck of present multinuclear platinum drugs, especially their severe systemic toxicity, might be overcome. (c) 2012 elsevier ltd. all rights reserved.
收录类别SCI收录期刊论文
语种英语
WOS记录号WOS:000310401000044
公开日期2013-04-22
源URL[http://ir.ciac.jl.cn/handle/322003/47874]  
专题长春应用化学研究所_长春应用化学研究所知识产出_期刊论文
推荐引用方式
GB/T 7714
Xiao HH,Song HQ,Zhang Y,et al. The use of polymeric platinum(IV) prodrugs to deliver multinuclear platinum(II) drugs with reduced systemic toxicity and enhanced antitumor efficacy[J]. biomaterials,2012,33(33):8657-8669.
APA Xiao HH.,Song HQ.,Zhang Y.,Qi RG.,Wang R.,...&Jing XB.(2012).The use of polymeric platinum(IV) prodrugs to deliver multinuclear platinum(II) drugs with reduced systemic toxicity and enhanced antitumor efficacy.biomaterials,33(33),8657-8669.
MLA Xiao HH,et al."The use of polymeric platinum(IV) prodrugs to deliver multinuclear platinum(II) drugs with reduced systemic toxicity and enhanced antitumor efficacy".biomaterials 33.33(2012):8657-8669.

入库方式: OAI收割

来源:长春应用化学研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。